What's happened
Kobayashi Pharmaceutical's beni kōji supplements have been linked to five deaths and over 200 hospitalizations in Japan. The health ministry is investigating the presence of a toxic compound, puberulic acid, in the products, raising concerns about regulatory oversight in the health supplement industry.
Why it matters
What the papers say
According to The Japan Times, the health ministry is investigating the toxic compound puberulic acid found in the supplements, which has been linked to serious health issues. The Independent reported that Kobayashi Pharmaceutical's delayed response to the health crisis has drawn public ire, with President Akihiro Kobayashi publicly apologizing for the company's handling of the situation. Al Jazeera noted that the scandal has prompted a review of Japan's health product approval system, indicating a potential shift in regulatory practices moving forward.
How we got here
The scandal erupted after reports of health issues associated with Kobayashi Pharmaceutical's beni kōji supplements surfaced in early 2024. The company has faced criticism for its delayed response to health complaints and the subsequent recall of its products.
Common question
More on these topics